1. Home
  2. QXO vs RGEN Comparison

QXO vs RGEN Comparison

Compare QXO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QXO
  • RGEN
  • Stock Information
  • Founded
  • QXO 1988
  • RGEN 1981
  • Country
  • QXO United States
  • RGEN United States
  • Employees
  • QXO N/A
  • RGEN N/A
  • Industry
  • QXO EDP Services
  • RGEN Medical/Dental Instruments
  • Sector
  • QXO Technology
  • RGEN Health Care
  • Exchange
  • QXO Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • QXO 6.5B
  • RGEN 7.6B
  • IPO Year
  • QXO N/A
  • RGEN N/A
  • Fundamental
  • Price
  • QXO $15.44
  • RGEN $144.46
  • Analyst Decision
  • QXO
  • RGEN Buy
  • Analyst Count
  • QXO 0
  • RGEN 12
  • Target Price
  • QXO N/A
  • RGEN $187.44
  • AVG Volume (30 Days)
  • QXO 2.6M
  • RGEN 531.4K
  • Earning Date
  • QXO 11-13-2024
  • RGEN 11-12-2024
  • Dividend Yield
  • QXO N/A
  • RGEN N/A
  • EPS Growth
  • QXO N/A
  • RGEN N/A
  • EPS
  • QXO N/A
  • RGEN N/A
  • Revenue
  • QXO $56,838,941.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • QXO $7.45
  • RGEN $2.23
  • Revenue Next Year
  • QXO $12,720.08
  • RGEN $10.07
  • P/E Ratio
  • QXO N/A
  • RGEN N/A
  • Revenue Growth
  • QXO 8.86
  • RGEN N/A
  • 52 Week Low
  • QXO $10.61
  • RGEN $113.50
  • 52 Week High
  • QXO $290.00
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • QXO 42.00
  • RGEN 45.89
  • Support Level
  • QXO $15.94
  • RGEN $143.91
  • Resistance Level
  • QXO $17.05
  • RGEN $161.24
  • Average True Range (ATR)
  • QXO 0.71
  • RGEN 6.16
  • MACD
  • QXO -0.17
  • RGEN -0.96
  • Stochastic Oscillator
  • QXO 8.70
  • RGEN 12.10

About QXO QXO Inc. Common Stock

QXO Inc provides technology solutions, primarily to clients in the manufacturing, distribution and service sectors. It provides consulting and professional services, specialized programming, training and technical support also offers solutions for accounting, financial reporting, enterprise resource planning, warehouse management systems, customer relationship management, business intelligence and other applications. Additionally, QXO develops and publishes its own proprietary software.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: